1. Leveraging digital health and care coordination to improve health services delivery to vulnerable populations. We embrace big data and technology to design, develop, and deliver economic and effective services for patients in the area of cancer screening and follow-up.
2. Development of intestinal organoids from humans to understand barrier function, systemic inflammation, inflammatory bowel disease, HIV persistence, infection, and microbiome. Approaches employed: organoid models, isolation of epithelial cells, lymphocytes, microbiota, and interventional trials such as fecal transplant.
January 10, 2020 - December 31, 2024 - Modeling intestinal dysfunction in HIV infection with organoid technology, Co-Principal Investigator. Sponsor: NIH/NIDDK, Sponsor Award ID: R01DK123746
July 14, 2016 - June 30, 2021 - Delaney AIDS Research Enterprise to Cure HIV, Co-Investigator. Sponsor: NIH/NIAID, Sponsor Award ID: UM1AI126611
January 1, 2016 - December 31, 2020 - Institute for HIV CURE Research, Co-Investigator. Sponsor: amfAR, Sponsor Award ID: 109301-59-RGRL
September 22, 2015 - August 31, 2020 - Intestinal MAIT Cells in HIV Infection, Co-Investigator. Sponsor: NIH, Sponsor Award ID: R01DK108350
Pomona College, Claremont, CA, BA, 1993-1997, Chemistry
Harvard Medical School, Boston, MA, MD, 1997-2002, Medicine
Harbor-UCLA Medical Center, Torrance, CA, Residency, 2002-2005, Internal Medicine
University of California, San Francisco, CA, Fellowship, 2005-2008, Gastroenterology
University of California, San Francisco, CA, MAS, 2006-2008, Epidemiology and Biostatistics